MarisaHillMDMS

Oncology • Stamford, CT

Hematologic Oncology

Senior Medical Monitor, Loxo Oncology at Lilly

Join to view full profile

Dr. Hill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hill's full profile

Already have an account?

Office
281 Tresser Blvd
Stamford, CT 06901
Is this information wrong?

Summary

I am a board-certified Hematologist and Oncologist. I was in practice for 9 years, specializing in Gastrointestinal Oncology. I now work in oncology drug development.

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
Ohio State University HospitalResidency, Internal Medicine, 2005 - 2008
University of Cincinnati College of MedicineClass of 2005

Certifications & Licensure

IL State Medical License 2008 - 2026
OH State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
Completed
Not Applicable

Publications & Presentations

PubMed

6 citations
Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus
Matthew M. Klairmont, Katherine Kopkash, Joanne Favuzza, Marisa E. Hill, Ruta Rao, Brett Mahon, Christopher W. Seder> ;Anticancer Research. 2015 Nov 1
Radiographic staging practices of newly diagnosed colorectal cancer vary according to medical specialty
Karen Ma, Sandeep S. Nayak, Hong Li, Kateri Evans, Amanda B. Francescatti, Marc I. Brand, Bruce A. Orkin, Marisa E. Hill, James Cameron, Sohrab Mobarhan, Joanne Favuzz...> ;Gastrointestinal Endoscopy. 2015 Sep 1
5 citations
A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas
M. E. Hill, Xiaobai Li, Sharon Kim, Angela Campbell, Kristy Culler, Mark Bloomston, Mark M. Zalupski, Gwen Hejna, Tanios Bekaii-Saab> ;Cancer Chemotherapy and Pharmacology. 2011 Mar 1
1 citations
A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies
Tanios Bekaii-Saab, M. E. Hill, Angela Campbell, Kavitha Kosuri, James D. Thomas, Miguel A. Villalona-Calero> ;Cancer Chemotherapy and Pharmacology. 2010 Apr 1
Biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in patients with metastatic adenocarcinoma of the pancreas (MAP): A dose-escalating phase I study.
Hill ME, Li X, Kim S, Culler K, Zalupski MM, Bekaii-Saab TS> ;J. Clin. Oncol.. 2008-05-20
Join now to see all

Hospital Affiliations

Glenbrook HospitalGlenview, Illinois
Evanston HospitalEvanston, Illinois
Skokie HospitalSkokie, Illinois
Highland Park HospitalHighland Park, Illinois